Table 3. Net Reclassification Improvement.
Stroke or Systemic Embolism (Number of Patients with Events) | ||||
---|---|---|---|---|
1-year Risk of S/SEE
Predicted
by CHA2DS2-VASc Model |
1-year Risk of S/SEE Predicted by ABC-Stroke Model | |||
<1% | 1–2% | >2% | ||
<1% | 1 | 1 | 1 | |
1–2% | 14 | 37 | 41 | |
>2% | 3 | 12 | 29 | |
Stroke or Systemic Embolism (Number of Patients with No Events) | ||||
1-year Risk of S/SEE
Predicted
by CHA2DS2-VASc Model |
1-year Risk of S/SEE Predicted by ABC-Stroke Model | |||
<1% | 1–2% | >2% | ||
<1% | 517 | 113 | 5 | |
1–2% | 1868 | 2870 | 1188 | |
>2% | 124 | 604 | 966 | |
Risk Score Comparison | ||||
ABC-Stroke vs. CHA2DS2-VASc Risk Scores | Percent Reclassification (n) | |||
Correctly Upclassified | 31.9% (43) | |||
Incorrectly Downclassfied | 20.9% (29) | |||
Incorrectly Upclassified | 15.8% (1306) | |||
Correctly Downclassified | 31.4% (2596) | |||
Net Reclassification Improvement at 3 years | 25.2% (95% CI, 13.1% – 46.1%) | |||
Major Bleeding (Number of Patients with Events) | ||||
1-year Risk of Major
Bleeding Predicted by HAS-BLED Model |
1-year Risk of Major Bleeding Predicted by ABC-Bleeding Model | |||
<1% | 1–2% | >2% | ||
<1% | 0 | 0 | 0 | |
1–2% | 1 | 6 | 3 | |
>2% | 0 | 32 | 209 | |
Major Bleeding (Number of Patients with No Events) | ||||
1-year Risk of Major
Bleeding Predicted by HAS-BLED Model |
1-year Risk of Major Bleeding Predicted by ABC-Bleeding Model | |||
<1% | 1–2% | >2% | ||
<1% | 0 | 0 | 0 | |
1–2% | 287 | 512 | 147 | |
>2% | 290 | 1460 | 4268 | |
Risk Score Comparison | ||||
ABC-Bleeding vs. HAS-BLED Risk Scores | Percent Reclassification (n) | |||
Correctly Upclassified | 1.2% (3) | |||
Incorrectly Downclassfied | 13.1% (33) | |||
Incorrectly Upclassified | 2.1% (147) | |||
Correcty Downclassified | 29.2% (2037) | |||
Net Reclassification Improvement at 3 years | 13.8% (95% CI, 8.0% – 22.8%) |
CI indicates confidence interval; S/SEE, stroke or systemic embolic event.